Updates in Hospital Medicine.
作者信息
Hageman Kevin
机构信息
Section of Hospital Medicine, Division of General Internal Medicine and Public Health, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee; Department of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, Tennessee.
出版信息
Brown J Hosp Med. 2022 Aug 26;1(3):37742. doi: 10.56305/001c.37742. eCollection 2022.
Abstract
摘要
相似文献
1
Updates in Hospital Medicine.医院医学进展
Brown J Hosp Med. 2022 Aug 26;1(3):37742. doi: 10.56305/001c.37742. eCollection 2022.
2
Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration.美国退伍军人事务部的多药物使用与阿片类药物使用障碍治疗的关系。
Addiction. 2021 Jan;116(1):96-104. doi: 10.1111/add.15116. Epub 2020 Jul 7.
3
Neurocognitive, psychiatric, and substance use characteristics in a diverse sample of persons with OUD who are starting methadone or buprenorphine/naloxone in opioid treatment programs.在阿片类药物治疗项目中开始使用美沙酮或丁丙诺啡/纳洛酮的不同阿片类物质使用障碍患者样本中的神经认知、精神和物质使用特征。
Addict Sci Clin Pract. 2021 Oct 24;16(1):64. doi: 10.1186/s13722-021-00272-4.
4
Treatment Outcomes Among Black Adults Receiving Medication for Opioid Use Disorder.黑人成人群体接受阿片类药物使用障碍治疗的结局。
J Racial Ethn Health Disparities. 2022 Aug;9(4):1557-1567. doi: 10.1007/s40615-021-01095-4. Epub 2021 Jul 12.
5
Pharmacogenomics-guided policy in opioid use disorder (OUD) management: An ethnically-diverse case-based approach.阿片类物质使用障碍（OUD）管理中的药物基因组学指导策略：一种基于不同种族案例的方法。
Addict Behav Rep. 2017 May 8;6:8-14. doi: 10.1016/j.abrep.2017.05.001. eCollection 2017 Dec.
6
Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population.在美国商业保险人群中，接受阿片类药物使用障碍治疗的个体中，可注射纳曲酮、口服纳曲酮和丁丙诺啡的使用和停药情况。
J Subst Abuse Treat. 2018 Feb;85:90-96. doi: 10.1016/j.jsat.2017.07.001. Epub 2017 Jul 3.
7
Buprenorphine prescribing for opioid use disorder in medical practices: can office-based out-patient care address the opiate crisis in the United States?在医疗实践中开具丁丙诺啡治疗阿片类药物使用障碍：基于诊室的门诊治疗能否解决美国的阿片类药物危机？
Addiction. 2019 Nov;114(11):1992-1999. doi: 10.1111/add.14733. Epub 2019 Jul 25.
8
Hospitalist perspectives on buprenorphine treatment for inpatients with opioid use disorder.住院医师对阿片类药物使用障碍住院患者丁丙诺啡治疗的看法。
Drug Alcohol Depend Rep. 2022 Oct 9;5:100106. doi: 10.1016/j.dadr.2022.100106. eCollection 2022 Dec.
9
A retrospective, observational study on medication for opioid use disorder during pregnancy and risk for neonatal abstinence syndrome.一项关于孕期阿片类药物使用障碍用药及新生儿戒断综合征风险的回顾性观察研究。
Fam Pract. 2022 Mar 24;39(2):311-315. doi: 10.1093/fampra/cmab121.
10
The Perceived Role of Withdrawal in Maintaining Opioid Addiction among Adults with Untreated Opioid Use Disorder: A Survey of Syringe Exchange Program Participants.成人未治疗阿片类药物使用障碍中停药对维持阿片类药物成瘾的感知作用：对注射器交换计划参与者的调查。
Subst Use Misuse. 2024;59(2):312-315. doi: 10.1080/10826084.2023.2269571. Epub 2023 Dec 28.
本文引用的文献
1
Albuterol-Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma.沙美特罗替卡松干粉吸入剂（舒利迭）治疗哮喘。
N Engl J Med. 2022 Jun 2;386(22):2071-2083. doi: 10.1056/NEJMoa2203163. Epub 2022 May 15.
2
Association of Medication Treatment for Opioid Use Disorder With Suicide Mortality.阿片类物质使用障碍药物治疗与自杀死亡率的关联。
Am J Psychiatry. 2022 Apr;179(4):298-304. doi: 10.1176/appi.ajp.2021.21070700.
3
Reliever-Triggered Inhaled Glucocorticoid in Black and Latinx Adults with Asthma.缓解触发型吸入性糖皮质激素在哮喘黑人和拉丁裔成年人中的应用。
N Engl J Med. 2022 Apr 21;386(16):1505-1518. doi: 10.1056/NEJMoa2118813. Epub 2022 Feb 26.
4
Substance use disorders and the risk of suicide mortality among men and women in the US Veterans Health Administration.美国退伍军人健康管理局中男性和女性的物质使用障碍与自杀死亡风险
Addiction. 2017 Jul;112(7):1193-1201. doi: 10.1111/add.13774. Epub 2017 Mar 16.
Zotero 插件